Innocoll Holdings plc 8-K SEC Filings

The name of the Company is Innocoll Holdings Public Limited Company.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

THIS LOAN AND GUARANTY AGREEMENT (this “Agreement”), dated May 9, 2017, by and among INNOCOLL PHARMACEUTICALS LIMITED, an Irish private limited company and having its registered office at Unit 9, Block D, Monksland Business Park, Monksla...

This Confidential Separation Agreement and General Release (“Agreement”) is hereby entered into by and between Jose Carmona (“you”) and Innocoll, Inc. (the “Company”). The purpose of this Agreement is to acknowledge and set forth the ter...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

Innocoll announces regulatory path forward after receiving formal FDA Type A meeting minutes regarding its XARACOLL® (bupivacaine HCl collagen-matrix implant) New Drug Application

Innocoll Holdings plc Announces Fourth Quarter and Full-Year 2016 Financial and Operating Results and Provides Corporate Update

The Board of Innocoll Holdings plc (“Innocoll” or the “Company”) (NASDAQ: INNL) notes anomalous movements in Innocoll’s share price this week and confirms that it is in discussions which may or may not lead to an offer for the entire iss...

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.